tiprankstipranks
Palvella Therapeutics (PVLA)
NASDAQ:PVLA
US Market
PVLA
Palvella Therapeutics
RESEARCH TOOLSreports

Palvella Therapeutics (PVLA) Stock News & Sentiment

779 Followers
Palvella Showcases QTORIN Platform Momentum and Commercial Readiness
Premium
Company Announcements
Palvella Showcases QTORIN Platform Momentum and Commercial Readiness
4d ago
8K
PVLA
3 Best Stocks to Buy Today, 4/1/2026, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Today, 4/1/2026, According to Top Analysts
9d ago
KOD
PVLA
De-Risked SELVA Trial Success and Scalable QTORIN Platform Underpin Buy Rating on Palvella
Premium
Ratings
De-Risked SELVA Trial Success and Scalable QTORIN Platform Underpin Buy Rating on Palvella
10d ago
PVLA
Positive Risk‑Reward on PVLA Driven by Low‑Risk QTORIN Rapamycin NDA and Strong Cash Runway
Premium
Ratings
Positive Risk‑Reward on PVLA Driven by Low‑Risk QTORIN Rapamycin NDA and Strong Cash Runway
10d ago
PVLA
Palvella Highlights 2025 Results and SELVA Phase 3 Progress
Premium
Company Announcements
Palvella Highlights 2025 Results and SELVA Phase 3 Progress
11d ago
8K
PVLA
PVLA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
PVLA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
13d ago
PVLA
Buy Rating Driven by Strong Phase 3 SELVA Data and Favorable FDA Pathway for QTORIN in Rare MLM Indication
Premium
Ratings
Buy Rating Driven by Strong Phase 3 SELVA Data and Favorable FDA Pathway for QTORIN in Rare MLM Indication
26d ago
PVLA
More PVLA News >

PVLA News on the Web

Palvella Showcases QTORIN Platform Momentum and Commercial Readiness
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Tilray (TLRY), Immunovant (IMVT) and Palvella Therapeutics (PVLA)
TipRanks News
Neutral
'Best of the best': Oppenheimer says buy these 12 small- and mid-cap stocks for upside through the end of 2026
Markets Insider
Neutral
Palvella Therapeutics Director Makes Bold New Insider Bet
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), MAIA Biotechnology, Inc. (MAIA) and Palvella Therapeutics (PVLA)
TipRanks News
Bullish
3 Best Stocks to Buy Today, 4/1/2026, According to Top Analysts
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Palvella Therapeutics (PVLA), Insight Molecular Diagnostics (IMDX) and Delcath Systems (DCTH)
TipRanks News
Bullish
Palvella Therapeutics (PVLA) Gets a Buy from BTIG
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
PVLA
Sector Average
Media Buzz
This Week1 articles
Weekly Average6 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PVLA’s Media Buzz Sentiment?
1 articles about PVLA were published this week. In an average week, 6 articles are published.
    What is PVLA’s weekly average amount of articles?
    In an average week, 6 articles about PVLA are published.
      What is PVLA’s News Sentiment?
      100% of articles about PVLA were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week